Pasithea Therapeutics Corp (KTTA) Financial Statements
153 Followers
Pasithea Therapeutics Corp Financial Overview
Pasithea Therapeutics Corp's market cap is currently $12.30M. The company's EPS TTM is $-2.46; its P/E ratio is -0.21; Pasithea Therapeutics Corp has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 15.06K |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ -5.09K | $ -2.21K |
| Operating Income | $ -20.86M | $ -14.25M | $ -15.98M | $ -12.59M | $ -4.51M |
| EBITDA | $ -20.19M | $ -13.60M | $ -15.33M | $ -11.72M | $ -2.17M |
| Net Income | $ -20.43M | $ -13.90M | $ -15.96M | $ -13.94M | $ -2.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 55.16M | $ 6.92M | $ 16.33M | $ 33.09M | $ 52.97M |
| Total Assets | $ 60.24M | $ 16.06M | $ 26.12M | $ 45.18M | $ 53.32M |
| Total Debt | $ 0.00 | $ 0.00 | $ 81.68K | $ 504.38K | $ 0.00 |
| Net Debt | $ -55.16M | $ -6.92M | $ -16.25M | $ -32.58M | $ -52.97M |
| Total Liabilities | $ 5.02M | $ 1.28M | $ 2.72M | $ 2.68M | $ 1.90M |
| Stockholders' Equity | $ 55.22M | $ 14.78M | $ 23.40M | $ 42.50M | $ 51.42M |
| Cash Flow | |||||
| Free Cash Flow | $ -15.21M | $ -13.92M | $ -13.46M | $ -13.80M | $ -3.20M |
| Operating Cash Flow | $ -15.21M | $ -13.92M | $ -13.43M | $ -13.69M | $ -3.17M |
| Investing Cash Flow | $ 11.00K | $ 0.00 | $ 399.01K | $ -2.93M | $ -21.50K |
| Financing Cash Flow | $ 63.52M | $ 4.52M | $ -3.73M | $ -3.21M | $ 55.93M |
Currency in USD
